 tissue plasminogen activator.14 We recommend
against the use of nonâ€“ catheter-directed, systemically administered thrombolytic agents for the treatment of iliofemoral thrombosis.
More directed strategies, including venous thrombectomy, catheter-directed pharmacologic thrombolysis, and pharmacomechanical thrombolysis, may be more
efficient, with fewer bleeding complications, and likely
have a role in the treatment of acute DVT. Surgical
